Therapy, General practice

Interaction of therapy on bone mineral density in male and female patients with rheumatoid arthritis

Prognosing the severity of the myasthenia gravis

Bioequivalence of a generic medicinal product Tiara Duo (valsartan and hydrochlorothiazide fixed-dose combination) to the reference medicinal product Co-Diovan^®: results of a randomized crossover clinical trial in healthy volunteers

Methods for overcoming resistance in treatment of arterial hypertension

Canephron^® N — proven efficiency and reasonable alternative to antibiotics in treatment of uncomplicated urinary tract infections

Bioequivalence of the medicinal product Preventor (rosuvastatin), film-coated tablets, to the reference medicinal product Crestor^® (rosuvastatin), film-coated tablets, in a randomized crossover clinical trial in healthy volunteers

Bioequivalence of amlodipine, hydrochlorothiazide and valsartan fixed-dose combination generic medicinal product (Tiara Trio^®) to the reference medicinal product Exforge HCT^®: results of a randomized crossover clinical trial in healthy volunteers

Medical and statistical and epidemiological characteristics of the prevalence of myasthenia gravis in Ukraine